KCNT1 inhibitors and methods of use

Abstract

The present invention is directed to, in part, compounds and compositions useful for preventing and / or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and / or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and / or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.